HomeIMCR • NASDAQ
add
Immunocore Holdings PLC - ADR
Nakaraang pagsara
$30.40
Sakop ng araw
$29.30 - $30.77
Sakop ng taon
$27.69 - $76.98
Market cap
1.49B USD
Average na Volume
295.93K
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 80.25M | 23.74% |
Gastos sa pagpapatakbo | 37.35M | 0.44% |
Net na kita | 8.74M | 864.24% |
Net profit margin | 10.89 | 677.86% |
Kita sa bawat share | 0.13 | 226.75% |
EBITDA | -7.47M | 42.86% |
Aktuwal na % ng binabayarang buwis | -43.38% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 901.28M | 102.93% |
Kabuuang asset | 1.08B | 91.51% |
Kabuuang sagutin | 706.81M | 235.62% |
Kabuuang equity | 377.83M | — |
Natitirang share | 50.03M | — |
Presyo para makapag-book | 4.03 | — |
Return on assets | -2.02% | — |
Return on capital | -2.51% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 8.74M | 864.24% |
Cash mula sa mga operasyon | 21.13M | 109.41% |
Cash mula sa pag-invest | -828.00K | -290.57% |
Cash mula sa financing | 198.00K | -98.09% |
Net change in cash | 32.78M | 169.97% |
Malayang cash flow | 24.65M | 368.96% |
Tungkol
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology. Wikipedia
Itinatag
2008
Website
Mga Empleyado
497
